{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:22:49Z","timestamp":1792592569963,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.dld.2024.05.020","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T01:10:03Z","timestamp":1717463403000},"page":"2111-2117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6734-7178","authenticated-orcid":false,"given":"Alberto","family":"Zanetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Campello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Spiezia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Gavasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Bulato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-191X","authenticated-orcid":false,"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Senzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.dld.2024.05.020_bib0001","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood-2012-12-473629","article-title":"The dimeric structure of factor XI and zymogen activation","volume":"121","author":"Geng","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.dld.2024.05.020_bib0002","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood-2009-02-203604","article-title":"Factor XI contributes to thrombin generation in the absence of factor XII","volume":"114","author":"Kravtsov","year":"2009","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.dld.2024.05.020_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11216314","article-title":"Clinical pharmacology of factor XI inhibitors: new therapeutic approaches for prevention of venous and arterial thrombotic disorders","volume":"11","author":"Campello","year":"2022","journal-title":"J Clin Med"},{"issue":"14","key":"10.1016\/j.dld.2024.05.020_bib0004","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood-2009-05-219915","article-title":"Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology","volume":"114","author":"Cushman","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.dld.2024.05.020_bib0005","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM200003093421004","article-title":"High levels of coagulation factor XI as a risk factor for venous thrombosis","volume":"342","author":"Meijers","year":"2000","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.dld.2024.05.020_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12154890","article-title":"Persistently high levels of coagulation factor XI as a risk factor for venous thrombosis","volume":"12","author":"Spiezia","year":"2023","journal-title":"J Clin Med"},{"issue":"13","key":"10.1016\/j.dld.2024.05.020_bib0007","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2005-12-023697","article-title":"Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII","volume":"108","author":"Doggen","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.dld.2024.05.020_bib0008","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1055\/s-0042-1742366","article-title":"Active FXI can independently predict ischemic stroke in anticoagulated atrial fibrillation patients: a cohort study","volume":"122","author":"Zabczyk","year":"2022","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.dld.2024.05.020_bib0009","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/QC259F09UNMKVP0R","article-title":"Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events","volume":"126","author":"Yang","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.dld.2024.05.020_bib0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1160\/TH08-04-0260","article-title":"Factor XI protein in human pancreas and kidney","volume":"100","author":"Cheng","year":"2008","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.dld.2024.05.020_bib0011","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/BF01311723","article-title":"Factors XI and XII are low in subjects with liver disease","volume":"28","author":"Walker","year":"1983","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.dld.2024.05.020_bib0012","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2024.05.020_bib0013","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2021.12.038","article-title":"Factor VIII\/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD","volume":"76","author":"Scheiner","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2024.05.020_bib0014","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2023.01.010","article-title":"Haemostasis in cirrhosis: understanding destabilising factors during acute decompensation","volume":"78","author":"Zanetto","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2024.05.020_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bpa.2020.01.003","article-title":"Perioperative management of antithrombotic treatment","volume":"34","author":"Zanetto","year":"2020","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.dld.2024.05.020_bib0016","article-title":"Whole blood thrombin generation shows a significant hypocoagulable state in patients with decompensated cirrhosis","author":"Zanetto","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.dld.2024.05.020_bib0017","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/HEP.0000000000000349","article-title":"The evolving knowledge on primary hemostasis in patients with cirrhosis: a comprehensive review","volume":"79","author":"Zanetto","year":"2024","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.dld.2024.05.020_bib0018","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2022.03.009","article-title":"Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death","volume":"77","author":"Zanetto","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2024.05.020_bib0019","article-title":"Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections","volume":"4","author":"Zanetto","year":"2022","journal-title":"JHEP Rep"},{"issue":"12","key":"10.1016\/j.dld.2024.05.020_bib0020","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/hep4.1781","article-title":"More pronounced hypercoagulable state and hypofibrinolysis in patients with cirrhosis with versus without HCC","volume":"5","author":"Zanetto","year":"2021","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.dld.2024.05.020_bib0021","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/liv.15183","article-title":"Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications","volume":"42","author":"Zanetto","year":"2022","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.dld.2024.05.020_bib0022","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2024.05.020_bib0023","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Subcommittee on control of anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.dld.2024.05.020_bib0024","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/hep.31443","article-title":"Acute kidney injury in decompensated cirrhosis is associated with both hypo-coagulable and hyper-coagulable features","volume":"72","author":"Zanetto","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2024.05.020_bib0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12933-023-01905-5","article-title":"Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study","volume":"22","author":"Paszek","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.dld.2024.05.020_bib0026","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jhep.2022.09.005","article-title":"Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis","volume":"78","author":"Zanetto","year":"2023","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.dld.2024.05.020_bib0027","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1172\/JCI119412","article-title":"Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis","volume":"99","author":"Von dem Borne","year":"1997","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.dld.2024.05.020_bib0028","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/liv.13873","article-title":"Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals","volume":"38","author":"Russo","year":"2018","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.dld.2024.05.020_bib0029","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1055\/s-0040-1713169","article-title":"Endothelial damage of the portal vein is associated with heparin-like effect in advanced stages of cirrhosis","volume":"120","author":"Shalaby","year":"2020","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.dld.2024.05.020_bib0030","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gutjnl-2019-319044","article-title":"Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS","volume":"69","author":"Queck","year":"2020","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.dld.2024.05.020_bib0031","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1080\/09537104.2022.2060499","article-title":"Reply to \"Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis\"","volume":"33","author":"Shalaby","year":"2022","journal-title":"Platelets"},{"issue":"5","key":"10.1016\/j.dld.2024.05.020_bib0032","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2024.05.020_bib0033","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the study of liver diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2024.05.020_bib0034","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jth.15562","article-title":"Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: guidance from the SSC of the ISTH","volume":"20","author":"Roberts","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.dld.2024.05.020_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2024.03.007","article-title":"Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome","author":"Zanetto","year":"2024","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.dld.2024.05.020_bib0036","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/hep4.1641","article-title":"Reduced clot stability by thromboelastography as a potential indicator of procedure-related bleeding in decompensated cirrhosis","volume":"5","author":"Zanetto","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.dld.2024.05.020_bib0037","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15889","article-title":"Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection","author":"Campello","year":"2024","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.dld.2024.05.020_bib0038","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.dld.2020.12.118","article-title":"Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis","volume":"53","author":"Campello","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"9","key":"10.1016\/j.dld.2024.05.020_bib0039","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ueg2.12472","article-title":"Toward a more precise prognostic stratification in acute decompensation of cirrhosis: the Padua model 2.0. United","volume":"11","author":"Zanetto","year":"2023","journal-title":"European Gastroenterol J"},{"issue":"5","key":"10.1016\/j.dld.2024.05.020_bib0040","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jhep.2020.12.017","article-title":"Systemic inflammation and disorders of hemostasis in the AD-ACLF syndrome","volume":"74","author":"Lisman","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2024.05.020_bib0041","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.020_bib0042","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0168-8278(23)00442-7","article-title":"Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial","volume":"78","author":"Puente Sanchez","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2024.05.020_bib0043","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.32596","article-title":"The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: recent evolution and open questions","volume":"77","author":"Deltenre","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dld.2024.05.020_bib0044","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jtha.2023.02.002","article-title":"Intraindividual variability over time of thrombin generation in patients with cirrhosis","volume":"21","author":"Sinegre","year":"2023","journal-title":"J Thromb Haemost"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824007801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824007801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T04:12:37Z","timestamp":1732507957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865824007801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1590865824007801"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.05.020","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}